Victor H. Gerbaudo, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fluorodeoxyglucose F18 | 23 | 2023 | 2016 | 3.050 |
Why?
|
Positron-Emission Tomography | 28 | 2023 | 6234 | 1.810 |
Why?
|
Radiopharmaceuticals | 23 | 2021 | 2645 | 1.580 |
Why?
|
Mesothelioma | 10 | 2022 | 818 | 1.290 |
Why?
|
Pleural Neoplasms | 9 | 2022 | 607 | 1.130 |
Why?
|
Molecular Imaging | 2 | 2021 | 828 | 0.820 |
Why?
|
Lung Neoplasms | 8 | 2023 | 13102 | 0.640 |
Why?
|
Quinolines | 1 | 2023 | 732 | 0.640 |
Why?
|
Esophageal Neoplasms | 3 | 2018 | 1583 | 0.610 |
Why?
|
Neuroendocrine Tumors | 1 | 2022 | 594 | 0.540 |
Why?
|
Radiometry | 2 | 2012 | 800 | 0.520 |
Why?
|
Tomography, X-Ray Computed | 17 | 2021 | 20129 | 0.490 |
Why?
|
Tomography, Emission-Computed | 4 | 2007 | 1144 | 0.480 |
Why?
|
Thorax | 2 | 2013 | 547 | 0.450 |
Why?
|
Thoracic Diseases | 1 | 2013 | 97 | 0.440 |
Why?
|
Radioactive Tracers | 1 | 2012 | 72 | 0.430 |
Why?
|
Liver Neoplasms | 5 | 2021 | 4253 | 0.350 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2021 | 3327 | 0.340 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2214 | 0.320 |
Why?
|
Yttrium Radioisotopes | 1 | 2009 | 93 | 0.320 |
Why?
|
Pulmonary Atelectasis | 1 | 2007 | 145 | 0.280 |
Why?
|
Microspheres | 1 | 2009 | 777 | 0.270 |
Why?
|
Propranolol | 1 | 2007 | 502 | 0.260 |
Why?
|
Safety | 2 | 2012 | 1186 | 0.250 |
Why?
|
Treatment Failure | 1 | 2011 | 2618 | 0.250 |
Why?
|
Thymus Hyperplasia | 2 | 2014 | 30 | 0.240 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5256 | 0.240 |
Why?
|
Adenocarcinoma | 3 | 2018 | 6364 | 0.220 |
Why?
|
Gallium Radioisotopes | 1 | 2023 | 178 | 0.220 |
Why?
|
Neoplasm Staging | 9 | 2022 | 11031 | 0.220 |
Why?
|
Drug Interactions | 1 | 2007 | 1460 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2011 | 9239 | 0.210 |
Why?
|
Occupational Exposure | 1 | 2012 | 1796 | 0.210 |
Why?
|
Radiography, Interventional | 3 | 2018 | 1095 | 0.210 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2007 | 1240 | 0.200 |
Why?
|
Image Enhancement | 3 | 2008 | 2921 | 0.200 |
Why?
|
Indium Radioisotopes | 2 | 2013 | 118 | 0.190 |
Why?
|
Brachytherapy | 1 | 2009 | 1248 | 0.190 |
Why?
|
Technetium Tc 99m Medronate | 2 | 2019 | 136 | 0.190 |
Why?
|
Digestive System Neoplasms | 2 | 2011 | 87 | 0.180 |
Why?
|
Pleural Diseases | 2 | 2013 | 139 | 0.180 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 644 | 0.180 |
Why?
|
Esophagectomy | 2 | 2018 | 447 | 0.180 |
Why?
|
Minerals | 2 | 2019 | 275 | 0.170 |
Why?
|
Sarcoidosis | 2 | 2016 | 506 | 0.170 |
Why?
|
Nitrogen Radioisotopes | 2 | 2018 | 44 | 0.170 |
Why?
|
Nuclear Medicine | 2 | 2012 | 233 | 0.170 |
Why?
|
Brain Neoplasms | 2 | 2010 | 8863 | 0.160 |
Why?
|
Radionuclide Imaging | 4 | 2012 | 2031 | 0.150 |
Why?
|
Osteomyelitis | 2 | 2013 | 402 | 0.140 |
Why?
|
Humans | 47 | 2023 | 744343 | 0.140 |
Why?
|
Mesenchymal Stem Cells | 2 | 2019 | 1632 | 0.130 |
Why?
|
Adipose Tissue | 1 | 2007 | 3279 | 0.130 |
Why?
|
Ablation Techniques | 1 | 2018 | 249 | 0.130 |
Why?
|
Nephritis | 1 | 2016 | 159 | 0.130 |
Why?
|
Brain Death | 2 | 2012 | 348 | 0.130 |
Why?
|
Salivary Glands | 1 | 2016 | 229 | 0.120 |
Why?
|
Mediastinal Cyst | 1 | 2014 | 29 | 0.120 |
Why?
|
Pseudolymphoma | 1 | 2014 | 30 | 0.120 |
Why?
|
Pentose Phosphate Pathway | 1 | 2014 | 124 | 0.120 |
Why?
|
Lacrimal Apparatus | 1 | 2016 | 225 | 0.120 |
Why?
|
Osteogenesis | 2 | 2019 | 1299 | 0.120 |
Why?
|
Phantoms, Imaging | 4 | 2013 | 2480 | 0.120 |
Why?
|
Gamma Cameras | 2 | 2003 | 36 | 0.110 |
Why?
|
Mediastinal Diseases | 1 | 2013 | 89 | 0.110 |
Why?
|
Technetium | 1 | 2013 | 334 | 0.110 |
Why?
|
Prognosis | 4 | 2022 | 29063 | 0.110 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2013 | 112 | 0.110 |
Why?
|
Bone Matrix | 1 | 2013 | 118 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2013 | 251 | 0.100 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2014 | 210 | 0.100 |
Why?
|
Pilot Projects | 3 | 2018 | 8324 | 0.100 |
Why?
|
Retrospective Studies | 12 | 2021 | 77449 | 0.100 |
Why?
|
Radiation Monitoring | 1 | 2012 | 98 | 0.100 |
Why?
|
Calcification, Physiologic | 2 | 2019 | 169 | 0.100 |
Why?
|
Sensitivity and Specificity | 6 | 2014 | 14722 | 0.100 |
Why?
|
Thoracic Injuries | 1 | 2013 | 272 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2013 | 1107 | 0.100 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2013 | 282 | 0.100 |
Why?
|
Middle Aged | 18 | 2021 | 213383 | 0.090 |
Why?
|
Aged | 17 | 2021 | 163280 | 0.090 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2011 | 145 | 0.090 |
Why?
|
Whole Body Imaging | 1 | 2012 | 280 | 0.090 |
Why?
|
Medical Informatics Applications | 1 | 2012 | 186 | 0.090 |
Why?
|
Quality Assurance, Health Care | 2 | 2012 | 2212 | 0.090 |
Why?
|
Automation | 1 | 2012 | 584 | 0.090 |
Why?
|
Bone Marrow | 2 | 2019 | 2948 | 0.090 |
Why?
|
Neoplasms | 2 | 2010 | 21683 | 0.090 |
Why?
|
Neoplasm Metastasis | 2 | 2011 | 4851 | 0.090 |
Why?
|
Injections | 1 | 2012 | 840 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2013 | 2327 | 0.090 |
Why?
|
Thymus Gland | 1 | 2014 | 1267 | 0.080 |
Why?
|
Thoracic Vertebrae | 1 | 2013 | 608 | 0.080 |
Why?
|
Radiation Protection | 1 | 2012 | 419 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2015 | 2503 | 0.080 |
Why?
|
Spinal Diseases | 1 | 2013 | 538 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2011 | 6895 | 0.080 |
Why?
|
Radiation Injuries | 1 | 2016 | 1180 | 0.080 |
Why?
|
Motion | 2 | 2011 | 798 | 0.080 |
Why?
|
Adult | 17 | 2021 | 214055 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2015 | 2109 | 0.080 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2007 | 66 | 0.080 |
Why?
|
Microwaves | 2 | 2020 | 191 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1119 | 0.080 |
Why?
|
Male | 19 | 2020 | 350118 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2011 | 537 | 0.070 |
Why?
|
Autophagy | 1 | 2015 | 1300 | 0.070 |
Why?
|
Reproducibility of Results | 6 | 2014 | 19905 | 0.070 |
Why?
|
Data Mining | 1 | 2012 | 537 | 0.070 |
Why?
|
Amyloidosis | 1 | 2013 | 795 | 0.070 |
Why?
|
Estradiol | 1 | 2014 | 2020 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11524 | 0.070 |
Why?
|
Lung | 3 | 2011 | 9856 | 0.070 |
Why?
|
Goats | 2 | 2019 | 171 | 0.070 |
Why?
|
Necrosis | 1 | 2010 | 1643 | 0.070 |
Why?
|
Biological Transport | 1 | 2011 | 2118 | 0.070 |
Why?
|
Tissue Scaffolds | 1 | 2013 | 956 | 0.070 |
Why?
|
Biopsy, Needle | 1 | 2011 | 1641 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57776 | 0.070 |
Why?
|
Female | 20 | 2021 | 380194 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1170 | 0.060 |
Why?
|
Technetium Tc 99m Pyrophosphate | 1 | 2004 | 44 | 0.060 |
Why?
|
Pneumonectomy | 1 | 2012 | 1094 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2727 | 0.060 |
Why?
|
Abdomen | 1 | 2011 | 1118 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15076 | 0.060 |
Why?
|
Polystyrenes | 1 | 2004 | 112 | 0.060 |
Why?
|
Radioactive Hazard Release | 1 | 2004 | 14 | 0.060 |
Why?
|
Radiography, Thoracic | 1 | 2011 | 1265 | 0.060 |
Why?
|
Respiratory Mechanics | 1 | 2008 | 686 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2012 | 1928 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2019 | 11483 | 0.060 |
Why?
|
Lung Diseases | 1 | 2013 | 1886 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2012 | 8949 | 0.060 |
Why?
|
Pyrimidines | 1 | 2015 | 2942 | 0.060 |
Why?
|
Artifacts | 2 | 2011 | 1904 | 0.060 |
Why?
|
Titanium | 1 | 2004 | 494 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2007 | 4034 | 0.050 |
Why?
|
Pleura | 1 | 2002 | 235 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2014 | 12959 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2012 | 2728 | 0.050 |
Why?
|
Myocardium | 1 | 2013 | 4776 | 0.050 |
Why?
|
Heart Diseases | 1 | 2013 | 2788 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2014 | 35421 | 0.050 |
Why?
|
Societies, Medical | 1 | 2012 | 3743 | 0.050 |
Why?
|
Prospective Studies | 4 | 2018 | 53288 | 0.040 |
Why?
|
Administration, Oral | 1 | 2007 | 3913 | 0.040 |
Why?
|
Mediastinal Neoplasms | 1 | 2002 | 423 | 0.040 |
Why?
|
Osteoblasts | 1 | 2004 | 1166 | 0.040 |
Why?
|
Algorithms | 3 | 2011 | 13881 | 0.040 |
Why?
|
Public Opinion | 1 | 2022 | 477 | 0.040 |
Why?
|
Preoperative Care | 1 | 2007 | 2250 | 0.040 |
Why?
|
Biopsy | 1 | 2010 | 6756 | 0.040 |
Why?
|
Disaster Planning | 1 | 2004 | 549 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39050 | 0.040 |
Why?
|
Perfusion | 1 | 2021 | 1360 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 7023 | 0.030 |
Why?
|
Parotid Gland | 1 | 2016 | 168 | 0.030 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2015 | 83 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2007 | 8642 | 0.030 |
Why?
|
Glucose Transporter Type 2 | 1 | 2014 | 62 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2014 | 192 | 0.030 |
Why?
|
Drug Implants | 1 | 2014 | 244 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 351 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2004 | 2759 | 0.030 |
Why?
|
NADP | 1 | 2014 | 226 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 3507 | 0.030 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2014 | 207 | 0.030 |
Why?
|
Thymoma | 1 | 2014 | 186 | 0.030 |
Why?
|
Porosity | 1 | 2013 | 362 | 0.030 |
Why?
|
Thymus Neoplasms | 1 | 2014 | 268 | 0.030 |
Why?
|
Iohexol | 1 | 2012 | 196 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 964 | 0.020 |
Why?
|
Culture Media | 1 | 2013 | 908 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2011 | 5078 | 0.020 |
Why?
|
Time Factors | 4 | 2014 | 40075 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 63114 | 0.020 |
Why?
|
Diaphragm | 1 | 2011 | 349 | 0.020 |
Why?
|
Foot | 1 | 2013 | 527 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2013 | 865 | 0.020 |
Why?
|
Quality Control | 1 | 2012 | 841 | 0.020 |
Why?
|
Cohort Studies | 2 | 2014 | 40561 | 0.020 |
Why?
|
Brain | 2 | 2008 | 26385 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1995 | 1572 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1856 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 16689 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2593 | 0.020 |
Why?
|
Pleural Effusion, Malignant | 1 | 2009 | 101 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3701 | 0.020 |
Why?
|
Energy Transfer | 1 | 2007 | 109 | 0.020 |
Why?
|
Cattle | 1 | 2013 | 3922 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 20822 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2077 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2971 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2013 | 3144 | 0.020 |
Why?
|
Documentation | 1 | 2012 | 871 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5892 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2007 | 498 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2938 | 0.020 |
Why?
|
Metabolomics | 1 | 2014 | 1484 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 1678 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2889 | 0.020 |
Why?
|
Thoracic Surgical Procedures | 1 | 2009 | 342 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2916 | 0.020 |
Why?
|
Subtraction Technique | 1 | 2007 | 525 | 0.020 |
Why?
|
Nuclear Medicine Department, Hospital | 1 | 2004 | 14 | 0.020 |
Why?
|
Alloys | 1 | 2004 | 122 | 0.020 |
Why?
|
Health Physics | 1 | 2004 | 23 | 0.020 |
Why?
|
Cell Survival | 1 | 2014 | 5882 | 0.010 |
Why?
|
Decontamination | 1 | 2004 | 69 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 2849 | 0.010 |
Why?
|
Tissue Culture Techniques | 1 | 2004 | 290 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1995 | 4577 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6622 | 0.010 |
Why?
|
3T3 Cells | 1 | 2004 | 1101 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3086 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 19229 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2013 | 1880 | 0.010 |
Why?
|
Liver | 1 | 2018 | 7474 | 0.010 |
Why?
|
Extremities | 1 | 2007 | 865 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2716 | 0.010 |
Why?
|
Glucose | 1 | 2014 | 4397 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6459 | 0.010 |
Why?
|
Heart | 1 | 1995 | 4467 | 0.010 |
Why?
|
Signal Transduction | 2 | 2015 | 23403 | 0.010 |
Why?
|
Patient Simulation | 1 | 2004 | 309 | 0.010 |
Why?
|
Animals | 4 | 2019 | 168757 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2924 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3616 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2007 | 1534 | 0.010 |
Why?
|
Coronary Disease | 1 | 1995 | 6077 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 2004 | 603 | 0.010 |
Why?
|
Leukocytes | 1 | 2007 | 2043 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 85781 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10252 | 0.010 |
Why?
|
DNA | 1 | 2013 | 7301 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5300 | 0.010 |
Why?
|
Safety Management | 1 | 2004 | 783 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9438 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9313 | 0.010 |
Why?
|
Rats | 1 | 2014 | 24260 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12354 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2007 | 2635 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10481 | 0.010 |
Why?
|
Triage | 1 | 2004 | 976 | 0.010 |
Why?
|
Bone and Bones | 1 | 2007 | 2575 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 5987 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8089 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4042 | 0.010 |
Why?
|
Ammonia | 1 | 1995 | 239 | 0.010 |
Why?
|
Palliative Care | 1 | 2009 | 3493 | 0.010 |
Why?
|
Mice | 2 | 2014 | 81183 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2003 | 2731 | 0.010 |
Why?
|
Vascular Resistance | 1 | 1995 | 936 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 23338 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 56430 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13695 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 2004 | 7659 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1995 | 3107 | 0.000 |
Why?
|